REFERENCES

1. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993;34:453-68.

2. Berg AT, Berkovic SF, Brodie MJ, et al.

3. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-19.

4. Neligan A, Bell GS, Elsayed M, Sander JW, Shorvon SD. Treatment changes in a cohort of people with apparently drug-resistant epi­lepsy: an extended follow-up. J Neurol Neurosurg Psychiatry 2012;83:810-13.

5. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug re­sistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010;51:1069-77.

6. National Institute for Health and Care Excellence (NICE). Epilepsies: Diagnosis and Management. Clinical guideline [CG137], updated 2018 London: NICE; 2012. Available at: https:// www.nice.org.uk/guidance/cg137.

7. Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17.

8. Campbell E, Kennedy F, Russell A, et al. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. J Neurol Neurosurg Psychiatry 2014;85:1029-34.

9. Samren EB, van Duijn CM, Christiaens GC, Hofman A, Lindhout D. Antiepileptic drug regimens and major congenital abnormal­ities in the offspring. Ann Neurol 1999;46:739-46.

10. Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts.

11. Vajda FJE, O'Brien T, Lander C, Graham J, Eadie M. The efficacy of the newer antiepileptic drugs in controlling seizures in preg­nancy. Epilepsia 2014;55:1229-34.

12. Vajda FJE, Hitchcock AA, Graham J, O'Brien TJ, Lander CM, Eadie MJ. The teratogenic risk of antiepileptic drug polytherapy. Epilepsia 2010;51:805-10.

13. Holmes LB, Mittendorf R, Shen A, Smith CR, Hernandez-Diaz S. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Arch Neurol 2011;68:1275-81.

14. Tomson T, Battino D. Teratogenic effects of antiepileptic drugs. Lancet Neurol 2012;11:803-13.

15. Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009;360:1597-605.

16. Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol 2013;12:244-52.

17. Bromley RL, Mawer G, Clayton-Smith J, Baker GA, Liverpool and Manchester Neurodevelopment Group. Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008;71:1923-24.

18. Christensen J, Gronborg TK, Sorensen MJ, et al. Prenatal val­proate exposure and risk of autism spectrum disorders and child­hood autism. JAMA 2013;309:1696-703.

19. European Medicines Agency. Procedure under Article 31 of Directive 2001/83/EC resulting from pharmacovigilance data. 2014. Available at: http://www.ema.europa.eu/docs/en_GB/document_ library/Referrals_document/Valproate_and_related_substances_ 31/Recommendation_provided_by_Pharmacovigilance_Risk_ Assessment_Committee/WC500177352.pdf (accessed 7 May 2016).

20. Tomson T, Marson A, Boon P, et al. Valproate in the treatment of epilepsy in girls and women of childbearing potential. Epilepsia 2015;56:1006-19.

21. Rauchenzauner M, Ehrensberger M, Prieschl M, et al. Generalized tonic-clonic seizures and antiepileptic drugs during pregnancy— a matter of importance for the baby? J Neurol 2013;260:484-88.

22. Battino D, Tomson T, Bonizzoni E, Craig J, et al. Seizure con­trol and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry. Epilepsia 2013;54:1621-27.

23. Reisinger TL, Newman M, Loring DW, Pennell PB, Meador KJ. Antiepileptic drug clearance and seizure frequency during preg­nancy in women with epilepsy. Epilepsy Behav 2013;29:13-18.

24. Harden CL, Hopp J, Ting TY, et al. Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): I. Obstetrical complications and change in seizure frequency: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2009;5:1229-36.

25. Viale L, Allotey J, Cheong-See F, et al. Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis. Lancet 2015;386:1845-52.

26. MacDonald SC, Bateman BT, McElrath TF, Hernandez-Diaz S. Mortality and morbidity during delivery hospitalization among pregnant women with epilepsy in the united states. JAMA Neurol 2015;72:981-88.

27. Adab N, Kini U, Vinten J, et al. The longer term outcome of chil­dren born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004;75:1575-83.

28. Edey S, Moran N, Nashef L. SUDEP and epilepsy-related mor­tality in pregnancy. Epilepsia 2014;55:e72-74.

29. EURAP Study Group. Seizure control and treatment in preg­nancy: observations from the EURAP epilepsy pregnancy registry. Neurology 2006;66:354-60.

30. Thomas SV, Syam U, Devi JS. Predictors of seizures during preg­nancy in women with epilepsy. Epilepsia 2012;53:e85-88.

31. Veiby G, Bjork M, Engelsen BA, Gilhus NE. Epilepsy and recom­mendations for breastfeeding. Seizure 2015;28:57-65.

32. McKay KA, Kwan V, Duggan T, Tremlett H. Risk factors associated with the onset of relapsing-remitting and primary progressive mul­tiple sclerosis: a systematic review. BioMed Res Int 2015;2015:817238.

33. Confavreux C, Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain 2006;129:606-16.

34. Finkelsztejn A, Brooks JBB, Paschoal FM, Fragoso YD. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG 2011;118:790-97.

35. Langer-Gould A, Beaber BE. Effects of pregnancy and breast­feeding on the multiple sclerosis disease course. Clin Immunol 2013;149:244-50.

36. Ramagopalan S, Yee I, Byrnes J, Guimond C, Ebers G, Sadovnick D. Term pregnancies and the clinical characteristics of multiple sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2012;83:793-95.

37. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995;118:253-61.

38. Hughes SE, Spelman T, Gray OM, et al. Predictors and dynamics of postpartum relapses in women with multiple sclerosis. Mult Scler 2014;20:739-46.

39. Tsui A, Lee MA. Multiple sclerosis and pregnancy. Curr Opin Obstet Gynecol 2011;23:435-39.

40. Bove R, Alwan S, Friedman JM, et al. Management of multiple sclerosis during pregnancy and the reproductive years: a system­atic review. Obstet Gynecol 2014;124:1157-68.

41. Coyle PK. Multiple sclerosis and pregnancy prescriptions. Expert Opin Drug Saf 2014;13:1565-68.

42. Pozzilli C, Pugliatti M, ParadigMS Group. An overview of preg­nancy-related issues in patients with multiple sclerosis. Eur J Neurol 2015;22 Suppl 2:34-39.

43. Lu E, Wang BW, Guimond C, et al. Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance. Expert Rev Neurother 2013;13:251-60.

44. Kelly VM, Nelson LM, Chakravarty EF. Obstetric outcomes in women with multiple sclerosis and epilepsy. Neurology 2009;73:1831-36.

45. Dahl J, Myhr K-M, Daltveit AK, Hoff JM, Gilhus NE. Pregnancy, delivery, and birth outcome in women with multiple sclerosis.

46. Mueller BA, Zhang J, Critchlow CW. Birth outcomes and need for hospitalization after delivery among women with multiple scler­osis. Am J Obstet Gynecol 2002;186:446-52.

47. Jalkanen A, Alanen A, Airas L, Finnish Multiple Sclerosis and Pregnancy Study Group. Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland. Mult Scler 2010;16:950-55.

48. van der Kop ML, Pearce MS, Dahlgren L, et al. Neonatal and de­livery outcomes in women with multiple sclerosis. Ann Neurol 2011;70:41-50.

49. Haider B, von Oertzen J. Neurological disorders. Best Pract Res Clin Obstet Gynaecol 2013;27:867-75.

50. Keesey JC. Clinical evaluation and management of myasthenia gravis. Muscle Nerve 2004;29:484-505.

51. Choi Decroos E, Hobson-Webb LD, Juel VC, Massey JM, Sanders DB. Do acetylcholine receptor and striated muscle antibodies pre­dict the presence of thymoma in patients with myasthenia gravis? Muscle Nerve 2014;49:30-34.

52. Batocchi AP, Majolini L, Evoli A, Lino MM, Minisci C, Tonali P. Course and treatment of myasthenia gravis during pregnancy. Neurology 1999;52:447-52.

53. Sussman J, Farrugia ME, Maddison P, Hill M, Leite MI, Hilton- Jones D. Myasthenia gravis: Association of British Neurologists’ management guidelines. PractNeurol 2015;15:199-206.

54. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000;62:385-92.

55. Ferrero S, Esposito F, Biamonti M, Bentivoglio G, Ragni N. Myasthenia gravis during pregnancy. Expert Rev Neurother 2008;8:979-88.

56. Sikka P, Joshi B, Aggarwal N, Suri V, Bhagat H. Distinguishing myasthenia exacerbation from severe preeclampsia: a diagnostic and therapeutic challenge. J Clin Diagn Res 2015;9:QD05-QD06.

57. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version).

58. Bigal ME, Bordini CA, Speciali JG. Etiology and distribution of headaches in two Brazilian primary care units. Headache 2000;40:241-47.

59. Facchinetti F, Allais G, Nappi RE, et al. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia 2009;29:286-92.

60. Wells RE, Turner DP, Lee M, Bishop L, Strauss L. Managing mi­graine during pregnancy and lactation. Curr Neurol Neurosci Rep 2016;16:40.

61. Tepper D. Pregnancy and lactation—migraine management. Headache 2015;55:607-608.

62. Rasmussen BK. Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 1993;53:65-72.

63. Cheelo M, Lodge CJ, Dharmage SC, et al. Paracetamol exposure in pregnancy and early childhood and development of childhood asthma: a systematic review and meta-analysis. Arch Dis Child 2015;100:81-89.

64. 0stensen ME, Skomsvoll JF. Anti- inflammatory pharmacotherapy during pregnancy. Expert Opin Pharmacother 2004;5:571-80.

65. Kozer E, Nikfar S, Costei A, Boskovic R, Nulman I, Koren G. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002;187:1623-30.

66. Becker WJ. Acute migraine treatment in adults. Headache 2015;55:778-93.

67. Ephross SA, Sinclair SM. Final results from the 16-year suma­triptan, naratriptan, and treximet pregnancy registry. Headache 2014;54:1158-72.

68. Marchenko A, Etwel F, Olutunfese O, Nickel C, Koren G, Nulman I. Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis. Headache 2015;55:490-501.

69. Nezvalova-Henriksen K, Spigset O, Nordeng H. Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study. Headache 2010;50:563-75.

70. Easterling TR. Pharmacological management of hypertension in pregnancy. Semin Perinatol 2014;38:487-95.

71. Magee LA, Schick B, Donnenfeld AE, et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996;174:823-28.

72. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev 2009; 1 :CD001218.

73. Darmency- Stamboul V, Chantegret C, Ferdynus C, et al. Antenatal factors associated with perinatal arterial ischemic stroke. Stroke 2012;43:2307-12.

74. Grear KE, Bushnell CD. Stroke and pregnancy: clinical presen­tation, evaluation, treatment, and epidemiology. Clin Obstet Gynecol 2013;56:350-59.

75. Wang PI, Chong ST, Kielar AZ, et al. Imaging of pregnant and lactating patients: part 1, evidence-based review and recom­mendations. AJR Am J Roentgenol 2012;198:778-84.

76. Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early man­agement of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2013;44:870-947.

77. Murugappan A, Coplin WM, Al-Sadat AN, et al. Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology 2006;66:768-70.

78. Demchuk AM. Yes, intravenous thrombolysis should be admin­istered in pregnancy when other clinical and imaging factors are favorable. Stroke 2013;44:864-85.

79. Moatti Z, Gupta M, Yadava R, Thamban S. A review of stroke and pregnancy: incidence, management and prevention. Eur J Obstet Gynecol Reprod Biol 2014;181:20-27.

80. Del Zotto E, Giossi A, Volonghi I, Costa P, Padovani A, Pezzini A. Ischemic Stroke during pregnancy and puerperium. Stroke Res Treat 2011;2011:606780.

81. Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient is­chemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:2160-236.

82. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005;106:401-407.

83. Lebaudy C, Hulot JS, Amoura Z, et al. Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy. Clin Pharmacol Ther 2008;84:370-77.

84. Burnett AE, Mahan CE, Vazquez SR, Oertel LB, Garcia DA, Ansell

J. Guidance for the practical management of the direct oral anti­coagulants (DOACs) in VTE treatment. J Thromb Thrombolysis 2016;41:206-32.

85. Coomarasamy A, Honest H, Papaioannou S, Gee H, Khan KS. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 2003;101:1319-32.

86. Kittner SJ, Stern BJ, Feeser BR, et al. Pregnancy and the risk of stroke. N Engl J Med 1996;335:768-74.

87. Sharshar T, Lamy C, Mas JL. Incidence and causes of strokes as­sociated with pregnancy and puerperium. A study in public hos­pitals of Ile de France. Stroke in Pregnancy Study Group. Stroke 1995;26:930-36.

88. Bateman BT, Schumacher HC, Bushnell CD, et al. Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome. Neurology 2006;67:424-29.

89. Connolly ES, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012;43:1711-37.

90. Razmara A, Bakhadirov K, Batra A, Feske SK. Cerebrovascular complications of pregnancy and the postpartum period. Curr Cardiol Rep 2014;16:532.

91. Hemphill JC, Greenberg SM, Anderson CS, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2015;46:2032-60.

92. Dias MS, Sekhar LN. Intracranial hemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery 1990;27:855-65.

93. Gross BA, Du R. Hemorrhage from arteriovenous malformations during pregnancy. Neurosurgery 2012;71:349-55.

94. Treadwell SD, Thanvi B, Robinson TG. Stroke in pregnancy and the puerperium. Postgrad Med J 2008;84:238-45.

95. Lee MJ, Hickenbottom S. Cerebrovascular disorders compli­cating pregnancy. UpToDate. Available at: https://www.uptodate. com/contents/cerebrovascular- disorders-complicating- pregnancy#H10 (accessed 31 December 2015).

96. Saposnik G, Barinagarrementeria F, Brown RD, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2011;42:1158-92.

97. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005;352:1791-98.

98. Jaigobin C, Silver FL. Stroke and pregnancy. Stroke 2000;31:2948-51.

99. Liang C-C, Chang S-D, Lai S-L, Hsieh C-C, Chueh H-Y, Lee T-H. Stroke complicating pregnancy and the puerperium. Eur J Neurol 2006;13:1256-60.

100. Bousser MG, Chiras J, Bories J, Castaigne P. Cerebral venous thrombosis—a review of 38 cases. Stroke 1985;16:199-213.

101. Ferro JM, Canhao P, Stam J, Bousser M-G, Barinagarrementeria F, ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35:664-70.

102. Pfefferkorn T, Crassard I, Linn J, Dichgans M, Boukobza M, Bousser M-G. Clinical features, course and outcome in deep cerebral venous system thrombosis: an analysis of 32 cases. J Neurol 2009;256:1839-45.

103. Chan W-S, Lee A, Spencer FA, et al. D-dimer testing in pregnant patients: towards determining the next ‘level” in the diagnosis of deep vein thrombosis. J Thromb Haemost 2010;8:1004-11.

104. Linn J, Ertl-Wagner B, Seelos KC, et al. Diagnostic value of multidetector-row CT angiography in the evaluation of throm­bosis of the cerebral venous sinuses. AJNR Am J Neuroradiol 2007;28:946-52.

105. Expert Panel on MR Safety, Kanal E, Barkovich AJ, et al. ACR guidance document on MR safe practices: 2013. J Magn Reson Imaging 2013;37:501-30.

106. Coutinho J, de Bruijn SF, Deveber G, Stam J. Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database Syst Rev 2011;8:CD002005.

107. Misra UK, Kalita J, Chandra S, Kumar B, Bansal V. Low mo­lecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: a randomized controlled trial. Eur J Neurol 2012;19:1030-36.

108. Mehraein S, Ortwein H, Busch M, Weih M, Einhaupl K, Masuhr F. Risk of recurrence of cerebral venous and sinus throm­bosis during subsequent pregnancy and puerperium. J Neurol Neurosurg Psychiatry 2003;74:814-16.

109. Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol 2012;11:906-17.

110. Miller TR, Shivashankar R, Mossa-B asha M, Gandhi D. Reversible cerebral vasoconstriction syndrome, part 1: epidemi­ology, pathogenesis, and clinical course. AJNR Am J Neuroradiol 2015;36:1392-99.

111. Fugate JE, Ameriso SF, Ortiz G, et al. Variable presentations of postpartum angiopathy. Stroke 2012;43:670-76.

112. Chen S-P, Fuh J-L, Wang S-J, et al. Magnetic resonance angiog­raphy in reversible cerebral vasoconstriction syndromes. Ann Neurol 2010;67:648-56.

113. Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysi­ology, and outstanding questions. Lancet Neurol 2015;14:914-25.

114. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein

AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010;85:427-32.

115. Meems M, Truijens S, Spek V, Visser LH, Pop VJM. Prevalence, course and determinants of carpal tunnel syndrome symptoms during pregnancy: a prospective study. BJOG 2015;122:1112-18.

116. Wand JS. Carpal tunnel syndrome in pregnancy and lactation. J Hand Surg 1990;15:93-95.

117. Wong CA, Scavone BM, Dugan S, et al. Incidence of postpartum lumbosacral spine and lower extremity nerve injuries. Obstet Gynecol 2003;101:279-88.

118. van Paassen BW, van der Kooi AJ, van Spaendonck-Zwarts KY, Verhamme C, Baas F, de Visser M. PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies. Orphanet J Rare Dis 2014;9:38.

119. Weinreb JC, Wolbarsht LB, Cohen JM, Brown CE, Maravilla KR. Prevalence of lumbosacral intervertebral disk abnormalities on MR images in pregnant and asymptomatic nonpregnant women. Radiology 1989;170:125-28.

120. Chou R, Qaseem A, Snow V, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007;147:478-91.

121. Black RA, Hill DA. Over-the-counter medications in pregnancy. Am Fam Physician 2003;67:2517-24.

122. Garmel SH, Guzelian GA, DAlton JG, DAlton ME. Lumbar disk disease in pregnancy. Obstet Gynecol 1997;89:821-22.

123. Hilsinger RL, Adour KK, Doty HE. Idiopathic facial paralysis, pregnancy, and the menstrual cycle. Ann Otol Rhinol Laryngol 1975;8:433-42.

124. Vrabec JT, Isaacson B, Van Hook JW. Bell’s palsy and pregnancy. Otolaryngol Head Neck Surg 2007;137:858-61.

125. Srivanitchapoom P, Pandey S, Hallett M. Restless legs syn­drome and pregnancy: a review. Parkinsonism Relat Disord 2014;20:716-22.

126. Allen RP, Picchietti DL, Garcia-Borreguero D, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria—history, rationale, description, and signifi­cance. Sleep Med 2014;15:860-73.

127. Gupta R, Dhyani M, Kendzerska T, et al. Restless legs syndrome and pregnancy: prevalence, possible pathophysiological mech­anisms and treatment. Acta Neurol Scand 2016;133:320-29.

128. Picchietti DL, Hensley JG, Bainbridge JL, et al. Consensus clin­ical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lac­tation. Sleep Med Rev 2015;22:64-77.

129. Cesnik E, Casetta I, Turri M, et al. Transient RLS during preg­nancy is a risk factor for the chronic idiopathic form. Neurology 2010;75:2117-20.

130. Tranquilli AL, Dekker G, Magee L, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A re­vised statement from the ISSHP. Pregnancy Hypertens 2014;4:97-104.

131. Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet 2016;387:999-1011.

132. Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2014;2:CD002252.

133. Altman D, Carroli G, Duley L, et al. Do women with pre­eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002;359:1877-90.

134. Mostello D, Kallogjeri D, Tungsiripat R, Leet T. Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births. Am J Obstet Gynecol 2008;199:55.e1-7.

135. Roberge S, Nicolaides KH, Demers S, Villa P, Bujold E. Prevention of perinatal death and adverse perinatal outcome using low-dose as­pirin: a meta-analysis. Ultrasound Obstet Gynecol 2013;41:491-99.

136. Rath WH, Hoferr S, Sinicina I. Amniotic fluid embolism: an interdisciplinary challenge: epidemiology, diagnosis and treat­ment. Dtsch Arztebl Int 2014;111:126-32.

137. Fitzpatrick KE, Tuffnell D, Kurinczuk JJ, Knight M. Incidence, risk factors, management and outcomes of amniotic-fluid em­bolism: a population- based cohort and nested case-control study. BJOG 2016;123:100-109.

138. Knight M, Tuffnell D, Brocklehurst P, Spark P, Kurinczuk JJ, UK Obstetric Surveillance System. Incidence and risk factors for am­niotic-fluid embolism. Obstet Gynecol 2010;115:910-17.

139. Conde-Agudelo A, Romero R. Amniotic fluid embolism: an evidence-based review. Am J Obstet Gynecol 2009;201:445. e1-13.

140. Karaca Z, Tanriverdi F, Unluhizarci K, Kelestimur F. Pregnancy and pituitary disorders. Eur J Endocrinol 2010;162: 453-75.

141. De Bellis A, Kelestimur F, Sinisi AA, et al. Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan’s syndrome. Eur J Endocrinol 2008;158:147-52.

142. Kele^timur F. Sheehan’s syndrome. Pituitary 2003;6:181-88.

143. Dokmeta^ HS, Kilicli F, Korkmaz S, Yonem O. Characteristic fea­tures of 20 patients with Sheehan’s syndrome. Gynecol Endocrinol 2006;22:279-83.

144. Kranick SM, Mowry EM, Colcher A, Horn S, Golbe LI. Movement disorders and pregnancy: a review of the literature. Mov Disord 2010;25:665-71.

145. Kim A, Choi CH, Han CH, Shin JC. Consecutive pregnancy with chorea gravidarum associated with moyamoya disease. J Perinatol 2009;29:317-19.

146. Cardoso F. Chorea gravidarum. Arch Neurol 2002;59:868-70.